000538 云南白药
交易中 09-24 14:38:51
资讯
新帖
简况
云南白药（000538）披露持股5%以上股东可交换债换股价格调整公告，9月22日股价上涨0.45%
证券之星 · 09-22 22:12
云南白药（000538）披露持股5%以上股东可交换债换股价格调整公告，9月22日股价上涨0.45%
云白国际回购2010万股，释放市场信心信号
投资观察 · 09-18
云白国际回购2010万股，释放市场信心信号
研报掘金丨中邮证券：首予云南白药云南白药，二线品种释放成长驱动力
格隆汇 · 09-17
研报掘金丨中邮证券：首予云南白药云南白药，二线品种释放成长驱动力
中邮证券：首次覆盖云南白药给予买入评级
证券之星 · 09-17
中邮证券：首次覆盖云南白药给予买入评级
云南白药：2026年特别分红权益分派实施公告
证券日报网 · 09-16
云南白药：2026年特别分红权益分派实施公告
套走6017万港元公款给自己买11只名表，万隆控股前行政总裁周泓获刑10年8个月
红星资本局 · 09-15
套走6017万港元公款给自己买11只名表，万隆控股前行政总裁周泓获刑10年8个月
云南白药获得发明专利授权：“一种包含重楼提取物、黄芪提取物和茯苓提取物的抗光损伤组合物及其应用”
证券之星 · 09-11
云南白药获得发明专利授权：“一种包含重楼提取物、黄芪提取物和茯苓提取物的抗光损伤组合物及其应用”
云南白药：9月7日接受机构调研，西部证券、招银理财参与
证券之星 · 09-08
云南白药：9月7日接受机构调研，西部证券、招银理财参与
云南白药上半年营收218.84亿元 拟现金分红18.52亿元
经济参考网 · 09-02
云南白药上半年营收218.84亿元 拟现金分红18.52亿元
诚通证券：给予云南白药增持评级
证券之星 · 08-31
诚通证券：给予云南白药增持评级
云南白药（000538）披露2026年第一次临时股东会通知，8月31日股价上涨0.78%
证券之星 · 08-31
云南白药（000538）披露2026年第一次临时股东会通知，8月31日股价上涨0.78%
股市必读：云南白药中报 - 第二季度单季净利润同比下降2.03%
证券之星 · 08-31
股市必读：云南白药中报 - 第二季度单季净利润同比下降2.03%
云南白药(000538)6月30日股东户数18.94万户，较上期增加11.87%
证券之星 · 08-29
云南白药(000538)6月30日股东户数18.94万户，较上期增加11.87%
图解云南白药中报：第二季度单季净利润同比下降2.03%
证券之星 · 08-29
图解云南白药中报：第二季度单季净利润同比下降2.03%
云南白药：2026年上半年净利润37.01亿元，同比增长1.88%
格隆汇 · 08-28
云南白药：2026年上半年净利润37.01亿元，同比增长1.88%
两融余额重获连增、半月增超730亿，市场回暖信号渐强？
第一财经 · 08-16
两融余额重获连增、半月增超730亿，市场回暖信号渐强？
2026西普会聚焦药店转型：从“卖药”到“健康驿站”的业态重构
智通财经 · 08-13
2026西普会聚焦药店转型：从“卖药”到“健康驿站”的业态重构
【私募调研记录】红筹投资调研云南白药
证券之星 · 08-12
【私募调研记录】红筹投资调研云南白药
【私募调研记录】盘京投资调研西部矿业、云南白药
证券之星 · 08-12
【私募调研记录】盘京投资调研西部矿业、云南白药
云南白药：8月11日接受机构调研，包括知名机构盘京投资的多家机构参与
证券之星 · 08-11
云南白药：8月11日接受机构调研，包括知名机构盘京投资的多家机构参与
加载更多
公司概况
公司名称：
云南白药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-12-15
主营业务：
云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品（自制）、批发零售、农产品。公司第17年上榜财富中文网发布的《财富中国500强排行榜》，位列第366位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。
发行价格：
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":49.92,"timestamp":1790231931000,"preClose":50.32,"halted":0,"volume":6260226,"delay":0,"changeRate":-0.0079,"floatShares":1784000000,"shares":1784000000,"eps":2.9266,"marketStatus":"交易中","change":-0.4,"latestTime":"09-24 14:38:51","open":50.41,"high":50.51,"low":49.81,"amount":314000000,"amplitude":0.0139,"askPrice":49.92,"askSize":12,"bidPrice":49.91,"bidSize":19,"shortable":0,"etf":0,"ttmEps":2.9266,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1790233200000},"marketStatusCode":2,"adr":0,"adjPreClose":50.32,"symbolType":"stock","openAndCloseTimeList":[[1790213400000,1790220600000],[1790226000000,1790233200000]],"highLimit":55.35,"lowLimit":45.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"isCdr":false,"pbRate":2.24,"roa":"--","peRate":17.057336,"roe":"9.04%","epsLYR":2.89,"committee":0.49697,"marketValue":89070000000,"turnoverRate":0.0035,"status":1,"floatMarketCap":89064000000},"requestUrl":"/m/hq/s/000538","defaultTab":"news","newsList":[{"id":"2669414044","title":"云南白药（000538）披露持股5%以上股东可交换债换股价格调整公告，9月22日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669414044","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669414044?lang=zh_cn&edition=full","pubTime":"2026-09-22 22:12","pubTimestamp":1790086351,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，云南白药报收于51.32元，较前一交易日上涨0.45%，最新总市值为915.68亿元。近日，云南白药集团股份有限公司披露《关于持股5％以上股东非公开发行可交换公司债券换股价格调整的提示性公告》。因云南白药实施2026年特别分红，向全体股东每10股派发现金红利10.38元（含税），根据债券募集说明书约定，换股价格由70.08元/股调整为69.04元/股，调整自2026年9月24日除权除息日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200041368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0196","BK0028","BK0187","LU1993786604.SGD","000538","LU1807302812.USD","BK0012","LU1960683339.HKD","BK0188","BK0175","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125601759","title":"云白国际回购2010万股，释放市场信心信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1125601759","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125601759?lang=zh_cn&edition=full","pubTime":"2026-09-18 23:32","pubTimestamp":1789745552,"startTime":"0","endTime":"0","summary":"9月18日（路透社）——云白国际有限公司于本周发布公告，宣布在2026年9月16日至9月18日期间，累计回购了2010万股公司股份。此举被视为公司管理层对自身价值的高度认可，同时也向市场传递出积极的信号。云白国际此次短时间内的大手笔回购，无疑为当前市场注入了一剂强心针。值得注意的是，这并非云白国际近期的首次回购操作。围绕该公司的更多动态，市场将保持密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000538","BK0012","BK0175","BK0164","LU1960683339.HKD","BK1121","BK1600","LU1993786604.SGD","BK0188","LU1807302812.USD","BK0239","BK0187","00030","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668695159","title":"研报掘金丨中邮证券：首予云南白药云南白药，二线品种释放成长驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2668695159","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668695159?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:33","pubTimestamp":1789626783,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0196","BK0028","BK0187","BK0239","LU1807302812.USD","161027","BK0164","000538","BK0175","LU1993786604.SGD","LU1960683339.HKD","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668898956","title":"中邮证券：首次覆盖云南白药给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2668898956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668898956?lang=zh_cn&edition=full","pubTime":"2026-09-17 13:00","pubTimestamp":1789621256,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,龙永茂近期对云南白药进行研究并发布了研究报告《营收利润稳健增长，二线品种释放成长驱动力》，首次覆盖云南白药给予买入评级。 盈利预测及投资建议 我们预计公司2026-2028年营收分别为425.71、440.99、456.98亿元，归母净利润分别为53.62、58.05、62.93亿元，当前股价对应PE分别为17、16、14倍，首次覆盖，给予“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700016793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667981214","title":"云南白药：2026年特别分红权益分派实施公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2667981214","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667981214?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:44","pubTimestamp":1789566240,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月16日，云南白药发布2026年特别分红权益分派实施公告称，公司获股东会审议通过的2026年特别分红具体方案为：以公司现有总股本1,784,262,603股为基数，向全体股东每10股派发现金红利10.38元(含税)，送红股0股，不以资本公积金转增股本，本次现金分红总金额为1,852,064,581.91元。股权登记日为2026年9月23日，除权除息日为2026年9月24日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-16/doc-inirzwqy9773161.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-16/doc-inirzwqy9773161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","BK0028","LU1807302812.USD","BK0175","BK0239","BK0164","000538","BK0188","BK0187","LU1960683339.HKD","SHRY","LU1993786604.SGD","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667640999","title":"套走6017万港元公款给自己买11只名表，万隆控股前行政总裁周泓获刑10年8个月","url":"https://stock-news.laohu8.com/highlight/detail?id=2667640999","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667640999?lang=zh_cn&edition=full","pubTime":"2026-09-15 21:09","pubTimestamp":1789477788,"startTime":"0","endTime":"0","summary":"红星资本局9月15日消息香港上市公司万隆控股集团（现已更名为云白国际有限公司，00030.HK）一起涉及逾6000万港元的疑似内部欺诈案有新进展。14日，香港高等法院判决万隆控股集团前行政总裁周泓，涉嫌利用职务便利虚构交易、套取公司巨额资金购置名表私用，欺诈罪名成立，判处监禁十年零八个月。法庭同时下令其赔偿公司5157万港元，并禁止其担任公司董事等职务15年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609153874977143.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609153874977143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1807302812.USD","BK0012","BK0187","BK0028","BK0164","BK0175","BK0196","LU1960683339.HKD","LU1993786604.SGD","BK0188","BK0239","000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666651304","title":"云南白药获得发明专利授权：“一种包含重楼提取物、黄芪提取物和茯苓提取物的抗光损伤组合物及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666651304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666651304?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:48","pubTimestamp":1789069739,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示云南白药新获得一项发明专利授权，专利名为“一种包含重楼提取物、黄芪提取物和茯苓提取物的抗光损伤组合物及其应用”，专利申请号为CN202610525250.X，授权日为2026年9月8日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100010280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1807302812.USD","BK0012","BK0187","BK0028","BK0164","BK0175","BK0196","LU1960683339.HKD","LU1993786604.SGD","BK0188","BK0239","000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340448","title":"云南白药：9月7日接受机构调研，西部证券、招银理财参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340448","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665340448?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:02","pubTimestamp":1788850949,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月7日云南白药发布公告称公司于2026年9月7日接受机构调研，西部证券陆伏崴、招银理财张英 郝雪梅参与。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800018957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0028","BK0196","LU1807302812.USD","BK0012","BK0187","BK0175","BK0276","BK0183","LU1993786604.SGD","002673","BK0188","BK0239","BK0164","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814770","title":"云南白药上半年营收218.84亿元 拟现金分红18.52亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814770","media":"经济参考网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664814770?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:35","pubTimestamp":1788352500,"startTime":"0","endTime":"0","summary":"上半年，公司实现营收218.84亿元，同比增长2.95%；归母净利润37.01亿元，同比增长1.88%，营收与利润保持双增。公司同时公告，拟实施2026年特别分红，现金分红总额18.52亿元。其中，云南白药气雾剂销售收入超15亿元，云南白药膏销售收入超7亿元。云南白药2026年半年报首次披露了聚药堂业绩情况，上半年，聚药堂实现主营业务收入3.18亿元，完成率为51.68%；实现净利润2236.71万元，完成率为37.47%。本次收购前，聚药堂2024年实现营收6.32亿元，净利润6932.83万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-02/doc-iniqmwqq4603531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000538","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077962","title":"诚通证券：给予云南白药增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663077962?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:05","pubTimestamp":1788174343,"startTime":"0","endTime":"0","summary":"诚通证券股份有限公司李志新近期对云南白药进行研究并发布了研究报告《2026年中报业绩点评：整体营收利润双增，二线大单品持续突破》，给予云南白药增持评级。 云南白药 事件： 公司发布2026年中期报告，期内营收利润同比双增。本文数据来源于诚通证券股份有限公司，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100030102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663607124","title":"云南白药（000538）披露2026年第一次临时股东会通知，8月31日股价上涨0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663607124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663607124?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:59","pubTimestamp":1788170342,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，云南白药报收于50.39元，较前一交易日上涨0.78%，最新总市值为899.09亿元。该股当日开盘50.51元，最高50.58元，最低50.0元，成交额达5.37亿元，换手率为0.6%。近日，云南白药集团股份有限公司发布《关于召开2026年第一次临时股东会的通知》。公告显示，公司将于2026年9月15日召开2026年第一次临时股东会，会议由第十一届董事会召集，现场会议地点为昆明市呈贡区云南白药街3686号公司白药空间二楼会议室。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100025634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0188","BK0196","LU1807302812.USD","BK0175","000538","LU1960683339.HKD","BK0187","BK0164","LU1993786604.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663904729","title":"股市必读：云南白药中报 - 第二季度单季净利润同比下降2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663904729","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663904729?lang=zh_cn&edition=full","pubTime":"2026-08-31 06:06","pubTimestamp":1788127587,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告2026年中报显示，上半年度公司主营收入218.84亿元，同比上升2.95%；归母净利润37.01亿元，同比上升1.88%；扣非净利润35.18亿元，同比上升1.66%；其中2026年第二季度，公司单季度主营收入102.81亿元，同比下降1.29%；单季度归母净利润16.64亿元，同比下降2.03%；单季度扣非净利润15.53亿元，同比下降1.29%；负债率25.56%，投资收益6.02亿元，财务费用1817.5万元，毛利率30.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012619","title":"云南白药(000538)6月30日股东户数18.94万户，较上期增加11.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012619","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012619?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:11","pubTimestamp":1787994719,"startTime":"0","endTime":"0","summary":"证券之星消息，近日云南白药披露，截至2026年6月30日公司股东户数为18.94万户，较3月31日增加2.01万户，增幅为11.87%。在中药行业个股中，云南白药股东户数高于行业平均水平，截至6月30日，中药行业平均股东户数为5.16万户。从股价来看，2026年3月31日至2026年6月30日，云南白药区间跌幅为11.08%，在此期间股东户数增加2.01万户，增幅为11.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU1993786604.SGD","BK0175","BK0187","BK0239","BK0188","BK0196","LU1807302812.USD","BK0164","LU1960683339.HKD","000538","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013399","title":"图解云南白药中报：第二季度单季净利润同比下降2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013399","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663013399?lang=zh_cn&edition=full","pubTime":"2026-08-29 03:32","pubTimestamp":1787945520,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药2026年中报显示，上半年度公司主营收入218.84亿元，同比上升2.95%；归母净利润37.01亿元，同比上升1.88%；扣非净利润35.18亿元，同比上升1.66%；其中2026年第二季度，公司单季度主营收入102.81亿元，同比下降1.29%；单季度归母净利润16.64亿元，同比下降2.03%；单季度扣非净利润15.53亿元，同比下降1.29%；负债率25.56%，投资收益6.02亿元，财务费用1817.5万元，毛利率30.06%。财报数据概要请见下图:本文数据来源于云南白药2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900007462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729064","title":"云南白药：2026年上半年净利润37.01亿元，同比增长1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729064","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662729064?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:55","pubTimestamp":1787914538,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","BK0164","BK0196","BK0012","LU1807302812.USD","BK0239","LU1960683339.HKD","BK0188","BK0175","000538","BK0187","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659917216","title":"两融余额重获连增、半月增超730亿，市场回暖信号渐强？","url":"https://stock-news.laohu8.com/highlight/detail?id=2659917216","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659917216?lang=zh_cn&edition=full","pubTime":"2026-08-16 19:30","pubTimestamp":1786879859,"startTime":"0","endTime":"0","summary":"两融余额连续增加，杠杆资金逐渐回流，A股的阶段性“去杠杆”是否已完成？Wind统计显示，8月4日至13日，两融余额已连续8个交易日增加，截至13日两融规模为2.68万亿元，较月初增加约730亿元。7月初至当月中旬，两融余额一度出现13连降，其间总规模减少超3000亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608163842526722.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608163842526722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["07233","600276","301308","688256","600183","LU1969619763.USD","LU1880383366.USD","BK0060","03188","000651","BK0028","BK0201","HK0000306701.USD","LU1880383440.USD","BK0207","LU0264606111.USD","LU1328277881.USD","LU0417516738.SGD","02827","83130","IE00B031HY20.USD","LU2008162690.USD","300308","159982","03130","BK0125","VGT","000895","LU0890818403.SGD","LU0348735423.USD","LU1130305938.SGD","IE00B12V2V27.USD","IE00BZ08YR35.GBP","399300","000538","301717","IE00BKZH1Z71.USD","000333","02846","IE0032431581.USD","LU0405327494.USD","IE0003795394.USD","300476","82846","LU1719994722.HKD","603986","LU0039217434.USD","83188","LU0231483743.USD","601318"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152531","title":"2026西普会聚焦药店转型：从“卖药”到“健康驿站”的业态重构","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152531","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659152531?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:35","pubTimestamp":1786624548,"startTime":"0","endTime":"0","summary":"今年1月，商务部等九部委发布《关于促进药品零售高质量发展的意见》，首次在全国层面推动药店从“药品销售终端”升级为”健康驿站”，强化专业服务、健康促进与应急保障三大核心功能。事实上，讨论至最后，与会嘉宾一致认为，健康驿站是行业唯一确定的转型方向，但绝非一蹴而就。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0985481810.HKD","BK4581","BK0175","000538","BK0196","LU1066053197.SGD","301017","IE00BLSP4452.SGD","LU0868494617.USD","LU0306807586.USD","IE00BLSP4239.USD","BK4550","SG9999011175.SGD","IE00B19Z3B42.SGD","BK0239","SGXZ57979304.SGD","SG9999001176.SGD","LU1960683339.HKD","LU2596442595.SGD","SG9999002224.SGD","SG9999004220.SGD","SG9999013999.USD","002727","BK0012","SG9999001176.USD","BK0183","LU0058720904.USD","LU0122379950.USD","BK4568","IE000M9KFDE8.USD","LU0456855351.SGD","LU1894683264.USD","PFE","000423","BK0209","OZEM","LU1066051498.USD","BK4534","BK4592","BK4588","BK0164","LU1023059063.AUD","SG9999003800.SGD","LU1057294990.SGD","BK0187","BK4599","IE00BBT3K403.USD","LU0321505439.SGD","IE00B19Z3581.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658358944","title":"【私募调研记录】红筹投资调研云南白药","url":"https://stock-news.laohu8.com/highlight/detail?id=2658358944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658358944?lang=zh_cn&edition=full","pubTime":"2026-08-12 08:13","pubTimestamp":1786493623,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月11日披露的机构调研信息，知名私募红筹投资近期对1家上市公司进行了调研，相关名单如下：1）云南白药 调研纪要：公司致力于打造具备持续生命力的核心产品，构建“大单品体系”，药品板块包括云南白药核心系列、气血康口服液等14个单品，健康品聚焦养元青洗护及抗敏、美白、儿童牙膏等高潜力赛道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081200006643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000538","BK0028","BK0012","LU1807302812.USD","BK0187","BK0196","BK0164","BK0188","LU1993786604.SGD","BK0175","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658944381","title":"【私募调研记录】盘京投资调研西部矿业、云南白药","url":"https://stock-news.laohu8.com/highlight/detail?id=2658944381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658944381?lang=zh_cn&edition=full","pubTime":"2026-08-12 08:13","pubTimestamp":1786493622,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月11日披露的机构调研信息，知名私募盘京投资近期对2家上市公司进行了调研，相关名单如下：1）西部矿业 调研纪要：西藏自治区税务局于2026年7月28日发布资源税调增公开征求意见通知，拟将选矿铜资源税税率由5.0%上调至9.0%，原矿铜税率由7.0%上调至10.0%，目前方案处于征求意见阶段，截止至2026年8月27日，最终执行标准尚存不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081200006642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0012","LU1960683339.HKD","LU1993786604.SGD","LU1934453819.USD","BK0242","BK0239","BK0175","BK0196","LU1807302812.USD","BK0028","BK0187","601168","LU1979443071.USD","BK0155","BK0188","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919512","title":"云南白药：8月11日接受机构调研，包括知名机构盘京投资的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658919512?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:32","pubTimestamp":1786458755,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月11日云南白药发布公告称公司于2026年8月11日接受机构调研，中金公司朱言音、盘京投资曹姗姗、深圳红筹投资王之栋、平安基金陶然、博时基金杨涛参与。云南白药2026年一季报显示，一季度公司主营收入116.03亿元，同比上升7.02%；归母净利润20.37亿元，同比上升5.31%；扣非净利润19.65亿元，同比上升4.12%；负债率25.31%，投资收益2.43亿元，财务费用1138.96万元，毛利率30.63%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0196","LU1807302812.USD","000538","BK0012","BK0164","BK0187","LU1960683339.HKD","LU1993786604.SGD","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790231932247,"stockEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0376},{"period":"3month","weight":0.0893},{"period":"6month","weight":-0.0278},{"period":"1year","weight":-0.0706},{"period":"ytd","weight":-0.0682}],"compareEarnings":[{"period":"1week","weight":0.0115},{"period":"1month","weight":0.014},{"period":"3month","weight":-0.0446},{"period":"6month","weight":0.0058},{"period":"1year","weight":0.03},{"period":"ytd","weight":-0.0081}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"189362人(较上一季度增加11.87%)","perCapita":"9421股","listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","registeredCapital":"178426万元","survey":" 云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品（自制）、批发零售、农产品。公司第17年上榜财富中文网发布的《财富中国500强排行榜》，位列第366位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。","listedPrice":3.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}